TP53 and cancer: Treatment of cancer cells with GSK2830371 has been found to increase the phosphorylation of PPM1D substrates, especially phosphorylated p53 at serine 15, and to induce growth inhibition and apoptosis in the cells harboring wild-type p53 [25–28].